Skip to main content
ZYME logo
ZYME
(NASDAQ)
Zymeworks Inc.
$29.19-- (--)
Loading... - Market loading

Zymeworks (ZYME) Stock Price & Financial Analysis

Zymeworks Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.09 - $29.99
52-Week High$31.34
52-Week Low$14.69
Open$29.81
Volume452.93K
Average Volume (3M)610.00K
Market Cap2.18B
Shares Outstanding74.69M
Price to Sales (P/S)26.83
Price to Book (P/B)13.33
EV/EBITDA-19.69
Revenue (TTM)81.26M
Net Income (TTM)-102.66M
Free Cash Flow (TTM)-77.12M
EPS (TTM)$-1.35
Profit Margin-126.33%
Operating Margin-140.29%
Return on Equity (ROE)-62.75%
Debt to Equity0.10
50-Day MA$25.50
200-Day MA$24.98
52-Week Change93.95%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Zymeworks

What is the current stock price for ZYME?

As of the latest trading session, ZYME stock trades at $29.19. The 52-week range is $14.69–$31.34, with a day range of $29.09–$29.99.

What is the P/E ratio for ZYME?

The P/E ratio (Price-to-Earnings) for ZYME is shown in the Key Statistics section. This valuation metric helps compare Zymeworks Inc. to industry peers.

Does ZYME pay dividends?

Zymeworks does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ZYME?

Based on 8 analysts, the consensus for ZYME is Buy.

What is the market cap of ZYME?

Zymeworks's market capitalization is $2.18B, classifying it as a mid-cap company. Zymeworks operates in the Healthcare sector within the Biotechnology industry.